Clinical trials have shown that vildagliptin is effective in significantly lowering glycosylated hemoglobin (HbA 1c), fasting plasma glucose, and prandial glucose levels. Beta-cell function may ...

Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...

Type 2 diabetes and obesity are intimately linked; reduction of bodyweight improves glycemic control, mortality and morbidity. Treating obesity in the diabetic is hampered as some diabetic ...

hyperglycemia was diagnosed with typical diabetic symptoms plus glycated hemoglobin A1C (HbA1c) ≥6.5% or fasting blood glucose (FBG) ≥7.0 mmol/L or fasting two-hour blood glucose (OGTT2h) ≥11.1 mmol/L ...